References

1. Hohenberger EC. Urinalysis with test strips Roche Diagnostics: 2004; pp. 1-112.

2. Foster K, Despotis G, and Scott MG. Point-of-care testing. Cost issues and impact on hospital operations. Clin Lab Med 2001;21(2):269-284.

3. Delaney B, Wilson S, Fitzmaurice D, Hyde C, and Hobbs R. Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Policy 2000; 5(1):37-41.

4. Daviaud J, Fournet D, Ballongue C, et al. Reliability and feasibility of pregnancy home-use tests: laboratory validation and diagnostic evaluation by 638 volunteers. Clin Chem 1993;39(1):53-59.

5. Alfthan H, Bjorses UM, Tiitinen A, and Stenman UH. Specificity and detection limit of ten pregnancy tests. Scand J Clin Lab Invest Suppl 1993;216:105-113.

6. O'Connor RE, Bibro CM, Pegg PJ, and Bouzoukis JK. The comparative sensitivity and specificity of serum and urine HCG determinations in the ED. Am J Emerg Med 1993;11(4):434-436.

7. Christensen H, Thyssen HH, Schebye O, and Berget A. Three highly sensitive "bedside" serum and urine tests for pregnancy compared. Clin Chem 1990;36(9): 1686-1688.

8. Levy S, Van Hook S, and Knight J. A review of Internet-based home drug-testing products for parents. Pediatrics 2004;113(4):720-726.

9. Kost GJ. Knowledge optimization theory and application to point-of-care testing. Stud Health Technol Inform 1999;62:189-190.

10. Bissell M. Point-of-care testing at the millennium. Crit Care Nurs Q 2001;24(1): 39-43.

11. Gouget B, Barclay J, and Rakotoambinina B. Impact of emerging technologies and regulations on the role of POCT. Clin Chim Acta 2001;307(1-2):235-240.

12. Delaney B, Wilson S, Fitzmaurice D, Hyde C, and Hobbs R. Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Policy 20005(1):37-41.

13. Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, and Mitchell JM. Validity testing of the EZ-SCREEN cannabinoid test. J Anal Toxicol 1993;17(5):292-298.

14. Yang JM. Toxicology and drugs of abuse testing at the point of care. Clin Lab Med 2001;21(2):363-374, ix-x.

15. Kadehjian LJ. Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens. J Anal Toxicol 200125(8):670-679.

16. Caplan YH and Goldberger BA. Alternative specimens for workplace drug testing. J Anal Toxicol 2001;25(5):396-399.

0 0

Post a comment